Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This project aims to implement and investigate a mindfulness-based stress reduction (MBSR) in people with multiple sclerosis (PwMS). The main objective is to implement MBSR intervention for PwMS in a major tertiary care clinic for PwMS. We will iteratively refine the intervention as required based on stakeholder feedback and any other emergent contextual findings.
Participants will be asked to take part in an 8-week MBSR course and report changes in anxiety, depression, quality of life, emotional regulation, self-compassion, mindfulness, and health services use.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Mindfulness-Based Stress Reduction | Other | 8-week Mindfulness-Based Stress Reduction course |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mindfulness-Based Stress Reduction | Behavioral | Eight iterations of the MBSR course will be delivered, over a total period of 24 months. Each iteration will take place over 8 weeks. Courses would consist of 8 weekly sessions, led by certified mindfulness instructors. Sessions will include core meditation practices, psychoeducation, and home practices. |
| Measure | Description | Time Frame |
|---|---|---|
| Recruitment | The investigators will measure the number of participants eligible for and recruited to the study. | 24 months |
| Retention | The investigators will measure the percentage of participants who complete outcome data. | 24 months |
| Adherence | The investigators will measure the number of participants who completed the mindfulness-based stress reduction course. | 24 months |
| Follow-up rates | The investigators will measure the percentage of participants who complete outcome measures pre-intervention, post-intervention, and at 3 months post-intervention. | 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life using the Multiple Sclerosis Impact Scale (MSIS-29) | Measured using the Multiple Sclerosis Impact Scale. Items on the scale have a Likert scale from 1-5, with a range of 0-100 total and higher scores indicating greater disability. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Robert Simpson | Contact | 416-360-4000 | 40047 | Robert.Simpson@unityhealth.to |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St. Michael's Hospital | Toronto | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000099024 | Mindfulness-Based Stress Reduction |
| ID | Term |
|---|---|
| D064866 | Mindfulness |
| D015928 | Cognitive Behavioral Therapy |
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Quality of Life using the EuroQol (EQ-5D-5L) |
Measured using the EQ-5D-5L. The total score ranges from 1-100, with higher values indicating better perceived health. |
| Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Anxiety | Measured using the Hospital Anxiety and Depression Scale. The total score ranges from 0-21, with higher values representing increased anxiety symptoms. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Depression | Measured using the Hospital Anxiety and Depression Scale. The total score ranges from 0-21, with higher values representing increased anxiety symptoms. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Health services use | Measured using the Client Services Receipt Inventory. This instrument is used to collect information on the use of health services. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Emotion regulation | Measured using the Difficulties in Emotion Regulation Scale - Short Form. Answers are assessed using a 5-point Likert scale. Higher values indicate greater difficulties in emotion regulation. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Self-compassion | Measured using the Self-Compassion Scale - Short Form. The total score ranges from a 1-5 Likert scale, with higher scores representing high self-compassion. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Mindfulness | Measured using the Five-facet Mindfulness Questionnaire. Answers are assessed using a 5-point Likert scale. Higher scores in each facet indicate higher levels of mindfulness. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Climate | Measured using the Group Climate Questionnaire-Engage Scale. Each item response is measured on a Likert scale from 0-6, with total subscale scores reflecting the average of responses. Higher scores indicate higher group engagement. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Therapeutic alliance | Measured using the Working Alliance Inventory. Each item is measured on a 7-point Likert scale, with a range of 36-252 total. Higher scores indicates stronger alliance. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Sleep | Measured using the Insomnia Severity Index. The total score ranges from 0-28, with higher scores indicating worse insomnia. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Pain Effects | Measured using the Pain Effects Scale. The total score ranges from 6-30, with higher scores indicating greater impact of pain on behavior and mood. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Fatigue | Measured using the Modified Fatigue Impact Scale. The total score ranges from 0-84, with higher scores indicating a greater impact of fatigue. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| Cognitive function | Measured using the Symbol Digits Modalities Test. The total score ranges from 0-110, with higher scores indicating better cognitive functioning. | Measured at baseline, 8-week follow-up, and 3-month follow-up |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D004191 |
| Behavioral Disciplines and Activities |